Skip to content

To study the utility of homoeopathic medicines in the treatment of Irritable Bowel Syndrome among adults

Utility of Mental Symptoms in the Homoeopathic management of Irritable Bowel Syndrome among adults an Experimental Non Controlled study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/096989
Enrollment
37
Registered
2025-11-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

Intervention1: Homoeopathic Management with respect to Indiviualisation: According to the requirement of the patient health Homoeopathic medicine in the form of pills will be prescribed during First d

Sponsors

Dr Sanjeevani Patiil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Irritable Bowel Syndrome of subtypes: IBS Constipation IBS Diarrhoea IBS Mixed Pre diagnosed patients of Irritable Bowel Syndrome of age group 18-45 years Patients of all the genders

Exclusion criteria

Exclusion criteria: Patients of Irritable Bowel Syndrome-Unsubtyped. Patients of Irritable Bowel Syndrome with red flag symptoms such as weight loss, nocturnal symptoms, family history of colon cancer, anemia, rectal bleeding, fever. Patients of Irritable Bowel Syndrome on any other medication within prior 1 month of study. Immunocompromised patients. Pregnant and lactating females.

Design outcomes

Primary

MeasureTime frame
A. Clinical outcome as per the Remedy Reaction pertaining to 1) Mental generals 2) Physical generals (concomitants, personal history) 3) Physical particulars (chief complaint) B. Statistical outcome will be assessed on Irritable Bowel Syndrome-Severity Scoring System 1) Improved: controls 2) Not improved: mild, moderate, severe scoresTimepoint: 1. Duration of study: 18 months 2. Duration of each case: Each case will be studied for 6 months 3. Duration of follow up: Each case will be followed up at the interval of 15 days or earlier, if required. Statistical outcome assessment will be done at baseline, 1 month, 3 months, and 6 months 10 days of treatment.

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactDr Chintan Mehta

Dr G D Pol Foundation YMT Homoeopathic Medical College and PG Institute

snehom5@gmail.com9322506976

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026